| Financial Year |
March 31 2023 |
| Monetary Funds |
156,616,336.52 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
156,900.00 |
| Accounts Receivable |
172,031,750.56 |
| Advances to Suppliers |
13,451,176.89 |
| Other Receivables |
125,821,394.47 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
9,535,581.00 |
| Inventories |
56,658,110.82 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
3,827,443.39 |
| Other Current Assets |
2,294,686.62 |
| Total Current Assets |
560,375,431.78 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
55,567,389.26 |
| Long-term Equity Investment |
94,268,857.86 |
| Investment Properties |
-- |
| Fixed Assetes |
208,886,450.76 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
152,325,126.03 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,015,784.53 |
| Deferred Income Tax Assets |
8,656,112.97 |
| Other Non-Current Assets |
10,218,655.16 |
| Sub-Total of Non-Current Assets |
554,209,814.23 |
| Total Assets |
1,114,585,246.01 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
151,431,544.77 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
8,435,936.23 |
| Taxes Payable |
6,694,243.06 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
154,920,291.85 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
22,043,552.36 |
| Other Current Liabilities |
521,923.18 |
| Sub-Total of Current Liabilities |
364,918,934.91 |
| Long-term Loans |
76,605,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
33,835,378.59 |
| Deferred Income Tax Liabilities |
425,038.22 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
116,494,479.47 |
| Total Liabilities |
481,413,414.38 |
| Paid-In Capital(Or Share Stock) |
302,065,356.00 |
| Capital Surplus |
1,067,168,282.59 |
| Surplus Reserve |
39,659,061.36 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-822,955,943.07 |
| Minority Stockholder's Interest |
47,396,337.77 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
585,775,493.86 |
| Owner's Equity（Stockholder's Equity） |
633,171,831.63 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,114,585,246.01 |
